13F HOLDINGS REPORT
STEMPOINT CAPITAL LP
Quarter ended Q2 2024 · Filed August 13, 2024 · Accession 0001420506-24-001376
Total Value
$340.3M
Positions
44
Other Managers
0
Confidential Omitted
No
Holdings (44)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,412,176 | $29.0M | 8.52% |
| 2 | ROIVANT SCIENCES LTD | ROIV | 2,712,741 | $28.7M | 8.43% |
| 3 | IMMUNOVANT INC | IMVT | 1,011,879 | $26.7M | 7.85% |
| 4 | CRINETICS PHARMACEUTICALS IN | CRNX | 551,095 | $24.7M | 7.25% |
| 5 | MERUS N V | N5749R100 | 288,668 | $17.1M | 5.02% |
| 6 | ARCELLX INC | ACLX | 280,709 | $15.5M | 4.55% |
| 7 | AMICUS THERAPEUTICS INC | FOLD | 1,495,047 | $14.8M | 4.36% |
| 8 | IMMUNOCORE HLDGS PLC | IMCR | 339,351 | $11.5M | 3.38% |
| 9 | APPLIED THERAPEUTICS INC | 03828A101 | 2,211,320 | $10.3M | 3.03% |
| 10 | MERCK & CO INC | MRK | 81,508 | $10.2M | 2.98% |
| 11 | GSK PLC | GLAXF | 245,933 | $9.5M | 2.78% |
| 12 | AUTOLUS THERAPEUTICS PLC | AUTL | 2,662,732 | $9.3M | 2.72% |
| 13 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 965,392 | $9.0M | 2.64% |
| 14 | CABALETTA BIO INC | CABA | 1,178,105 | $8.8M | 2.59% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 736,765 | $8.7M | 2.55% |
| 16 | BIOHAVEN LTD | BHVN | 233,255 | $8.1M | 2.38% |
| 17 | IMMATICS N.V | IMTX | 502,207 | $5.8M | 1.71% |
| 18 | DENALI THERAPEUTICS INC | DNLI | 251,010 | $5.8M | 1.71% |
| 19 | INSMED INC | INSM | 86,980 | $5.8M | 1.71% |
| 20 | CELLDEX THERAPEUTICS INC NEW | CLDX | 144,467 | $5.3M | 1.57% |
| 21 | LARIMAR THERAPEUTICS INC | LRMR | 704,349 | $5.1M | 1.50% |
| 22 | TSCAN THERAPEUTICS INC | TCRX | 845,069 | $4.9M | 1.45% |
| 23 | EDGEWISE THERAPEUTICS INC | EWTX | 271,057 | $4.9M | 1.43% |
| 24 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 101,479 | $4.6M | 1.35% |
| 25 | FULCRUM THERAPEUTICS INC | FULC | 696,464 | $4.3M | 1.27% |
| 26 | VISTAGEN THERAPEUTICS INC | VTGN | 1,231,833 | $4.3M | 1.26% |
| 27 | NURIX THERAPEUTICS INC | NRIX | 203,273 | $4.2M | 1.25% |
| 28 | PYXIS ONCOLOGY INC | PYXS | 1,202,675 | $4.0M | 1.17% |
| 29 | JANUX THERAPEUTICS INC | JANX | 92,949 | $3.9M | 1.14% |
| 30 | IDEAYA BIOSCIENCES INC | IDYA | 101,787 | $3.6M | 1.05% |
| 31 | SPYRE THERAPEUTICS INC | SYRE | 150,450 | $3.5M | 1.04% |
| 32 | PERSPECTIVE THERAPEUTICS INC | CATX | 343,810 | $3.4M | 1.01% |
| 33 | JASPER THERAPEUTICS INC | JSPRW | 143,775 | $3.3M | 0.96% |
| 34 | BLACK DIAMOND THERAPEUTICS I | BDTX | 674,198 | $3.1M | 0.92% |
| 35 | VIGIL NEUROSCIENCE INC | 92673K108 | 744,412 | $3.0M | 0.88% |
| 36 | NEUROGENE INC | NGNE | 78,601 | $2.9M | 0.84% |
| 37 | SILENCE THERAPEUTICS PLC | SLNCF | 124,866 | $2.4M | 0.70% |
| 38 | PROTARA THERAPEUTICS INC | TARA | 984,113 | $2.0M | 0.60% |
| 39 | HELIX ACQUISITION CORP II | HLXC | 200,000 | $2.0M | 0.60% |
| 40 | SURROZEN INC | SRZNW | 143,510 | $1.6M | 0.46% |
| 41 | VISTAGEN THERAPEUTICS INC | VTGN | 616,749 | $1.6M | 0.46% |
| 42 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 150,000 | $1.5M | 0.44% |
| 43 | PRAXIS PRECISION MEDICINES I | PRAX | 29,259 | $1.2M | 0.36% |
| 44 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 5,000,000 | $350,000 | 0.10% |